{"id":"e58a5e33-3d71-4aa2-b2a8-55c69489c47d","slug":"microsurgical-treatment-of-patients-with-refractory-epilepsy-and-mesial-temporal-cavernous-malformations-clinical-experience-of-a-tertiary-epilepsy-center","title":"Microsurgical treatment of patients with refractory epilepsy and mesial temporal cavernous malformations: Clinical experience of a tertiary epilepsy center","authors":["Lucas Crociati Meguins","Rodrigo Antônio Rocha da Cruz Adry","Sebastião Carlos da Silva Júnior","Carlos Umberto Pereira","Jean Gonçalves de Oliveira","Dionei Freitas de Morais","Gerardo Maria de Araújo Filho","Lúcia Helena Neves Marques"],"abstract":"Background: Mesiotemporal cavernous malformation can occur in 10-20% of patients with cerebral cavernomas and are frequently associated with refractory. Methods: A retrospective investigation was performed in the epilepsy clinic of a Brazilian tertiary referral epilepsy center, from January 2000 to March 2012. Results: A total of 21 patients were included in the study. Thirteen patients (62%) evolved to Engel I; 5 (24%) to Engel II, 2 (10%) to Engel III, and 1 (5%) to Engel IV. We observed that 10 (48%) patients with 12 years or less of epilepsy duration evolved to Engel I and 1 (5%) to Engel II; whereas from a total of 10 patients with epilepsy duration of more than 12 years, 3 (30%) evolved to Engel I and 7 (70%) to Engel II, III, or IV (P P1 ≠ P2). Conclusion: Postsurgical seizure outcome for temporal lobe epilepsy associated with mesiotemporal cavernomas is very satisfactory.","thumbnailUrl":"https://sni-digital-videos.s3.amazonaws.com/articles/e58a5e33-3d71-4aa2-b2a8-55c69489c47d/featured/hero-1782420785173.png","publishDate":"2015-11-16T00:00:00.000Z","doi":"10.4103/2152-7806.169552","categories":["Epilepsy","Original Article"],"fullTextUrl":"https://surgicalneurologyint.com/api/articles/e58a5e33-3d71-4aa2-b2a8-55c69489c47d/pdf"}